Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

Salix Central

K-Number: K243038 · 2025-03-27

Decision Date2025-03-27
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

Salix Central is a medical device manufactured by Artrya Limited. It received FDA 510(k) clearance on 2025-03-27 under approval number K243038. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the Salix Central?

Salix Central is a medical device that received FDA 510(k) clearance on 2025-03-27. It is manufactured by Artrya Limited. The 510(k) number is K243038.

When was Salix Central approved by the FDA?

Salix Central received FDA 510(k) clearance on 2025-03-27, under approval number K243038.

What company makes Salix Central?

Salix Central is manufactured by Artrya Limited.

What is the FDA product code for Salix Central?

The FDA product code for Salix Central is QIH.

Other Devices by Artrya Limited

Related Devices (Code: QIH)

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.